Telecom Healthcare Sector

ImmuCell

Market Cap: US$47.3m

An animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally.

Microba Life Sciences

Market Cap: AU$73.9m

Provides microbiome testing, supplements, and analysis services in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, Asia, and Ireland.

Sernova Biotherapeutics

Market Cap: CA$65.7m

Operates as a clinical-stage biotechnology company in Canada.

Opus Genetics

Market Cap: US$46.4m

A clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of inherited retinal diseases (IRDs).

Recce Pharmaceuticals

Market Cap: AU$72.4m

Recce Pharmaceuticals Ltd, discovers, develops, and commercializes synthetic anti–infectives in Australia, the United Kingdom, and the United States.

Camp4 Therapeutics

Market Cap: US$46.4m

A clinical-stage biopharmaceutical company, discovers and develops regulatory RNA-based therapeutics to treat a range of genetic diseases.

Radius Residential Care

Market Cap: NZ$78.3m

Provides health and aged care services for elderly and disabled people in New Zealand.

Apiam Animal Health

Market Cap: AU$71.7m

A vertically integrated animal health company, provides veterinary products and services to production and companion animals, and equine in Australia.

Celularity

Market Cap: US$45.9m

A clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases.

Mural Oncology

Market Cap: US$45.7m

Operates as a clinical-stage oncology company that focuses on discovering and developing immunotherapies for the treatment of patients with cancer.

Karyopharm Therapeutics

Market Cap: US$45.6m

A commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases in the United States.

Maverick Lifestyle

Market Cap: US$45.4m

Engages in the manufacture, branding, marketing, distribution, and sale of products infused with hemp-derived cannabinoids in the United States.

PMV Pharmaceuticals

Market Cap: US$45.0m

A precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer.

Basel Medical Group

Market Cap: US$44.5m

Provides healthcare services in Singapore.

Xilio Therapeutics

Market Cap: US$44.5m

A clinical-stage biotechnology company, engages in the discovery and development of tumor-activated immuno-oncology therapies.

Vitasora Health

Market Cap: AU$69.3m

An e-health SaaS company, researches, develops, and commercializes medical devices in Australia and the United States.

Adverum Biotechnologies

Market Cap: US$44.2m

A clinical-stage company, develops gene therapy product candidates to treat ocular diseases.

Neurizon Therapeutics

Market Cap: AU$68.9m

A clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases in Switzerland, Australia, the United States, and internationally.

Actinogen Medical

Market Cap: AU$68.9m

A biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia.

House of Jane

Market Cap: US$44.1m

Provides lifestyle therapy products.

Biodesix

Market Cap: US$44.0m

Operates as a diagnostic solutions company.

BioNxt Solutions

Market Cap: CA$61.4m

Engages in R&D and manufacturing of thin-film (sublingual) and skin patch (transdermal) drug delivery for neurological and autoimmune diseases, enhancing patient compliance and bioavailability.

Vicarious Surgical

Market Cap: US$43.8m

Develops and sells single-port surgical robot in the United States.

TELA Bio

Market Cap: US$43.5m

A commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy.

RenovoRx

Market Cap: US$43.1m

A clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment.

Medical Developments International

Market Cap: AU$67.0m

Manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally.

MedMira

Market Cap: CA$59.6m

A biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and technology platforms in North America, Europe, and internationally.

Mersana Therapeutics

Market Cap: US$42.4m

A clinical-stage biopharmaceutical company, develops antibody-drug conjugates (ADC) for cancer patients with unmet needs.

Anebulo Pharmaceuticals

Market Cap: US$41.9m

A clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States.

Avalo Therapeutics

Market Cap: US$41.7m

A clinical stage biotechnology company, focuses on the development of therapies for the treatment of immune dysregulation in the Unites States.

Nowtransit

Market Cap: US$41.6m

Distributes clinically tested and affordably priced products to battle the onslaught of bacteria and viruses.

Connect Biopharma Holdings

Market Cap: US$41.6m

A clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of T cell-driven inflammatory diseases.

Kronos Bio

Market Cap: US$41.5m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule therapeutics to treat cancer and other serious diseases in the United States.

ImpediMed

Market Cap: AU$64.8m

A medical technology company, manufactures, and sells bioimpedance spectroscopy (BIS) technology medical devices in the Unites States and Europe.

VolitionRx

Market Cap: US$41.5m

A multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and diseases associated with NETosis such as sepsis in the United States and internationally.

NRx Pharmaceuticals

Market Cap: US$41.4m

A clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain.